Outcomes are still associated to operator experience and institutional volume

This study is a retrospective analysis of 2,243,209 PCI stenting procedures in the USA between 2005 and 2009. During this period, a reduction in the number of PCI procedures was observed (also observed globally) from 53 in previous years to 33 procedures per operator per year, and from 1,024 to 693 per hospital per year.

 

Primary end point was in-hospital mortality and secondary end point was a composite of in-hospital mortality and peri-procedural complications.

 

Overall in-hospital mortality was 1.08% and peri-procedural complications rate was 7.10%, most common being vascular complications (2.01%), followed by cardiac complications (1.76%), respiratory failure (1.50%) and postoperative stroke (0.99%).

 

After adjustment for potential confounders, it was observed that In-hospital mortality and peri-procedural complications both increased significantly as PCI volume at operator level declined.

 

The chance of death or complications doubles among those operators with ≤15 PCIs a year, compared to those with >100 PCIs a year (10.1% vs 5.1% respectively; p<0.001). Operator volume also reduces in-hospital stay and associated costs.

 

Initially, a similar relationship was observed between outcomes and institutional volume; however, after adjusting by operator volume, the observed difference was considered non-significant.

 

Conclusion

In-hospital mortality rate in the context of PCI is low. The higher the number of procedures by operator, the lower mortality, complications, in-hospital stay and costs. 

 

Editorial Comment

Is there a magic number that will turn operators into experts? The last 2013 ACCF/AHA/SCAI issue recommended at least 50 PCIs a year per operator and 200 per center, and this is an amendment to the previous document that had recommended 75 per operator, a reasonable change given the decreasing number of procedures.

 

The study showed that an important number of operators did not reach the 50 annual procedures, which could be a problem for future PCIs, if this global decreasing tendency continues in the context of a clear relationship between outcomes and volume.

 

Original title: Impact of annual operator and institutional volume on percutaneous coronary intervention outcomes: a 5-year United States experience (2005-2009). 

Reference: Badheka AO et al. Circulation. 2014; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....